Krishna R Kalari, PhD

  • 2899 Citations
  • 27 Scopus h-Index
20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Krishna R Kalari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 2899 Citations
  • 27 Scopus h-Index
  • 94 Article
  • 3 Comment/debate
  • 1 Conference contribution
  • 1 Review article

Alternating em algorithm for a bilinear model in isoform quantification from RNA-seq data

Deng, W., Mou, T., Kalari, K. R., Niu, N., Wang, L., Pawitan, Y. & Vu, T. N., Feb 1 2020, In : Bioinformatics. 36, 3, p. 805-812 8 p.

Research output: Contribution to journalArticle

Open Access
  • Anastrozole has an association between degree of estrogen suppression and outcomes in early breast cancer and is a ligand for estrogen receptor

    Ingle, J. N., Cairns, J., Suman, V. J., Shepherd, L. E., Fasching, P. A., Hoskin, T. L., Singh, R. J., Desta, Z., Kalari, K. R., Ellis, M. J., Goss, P. E., Chen, B. E., Volz, B., Barman, P., Carlson, E. E., Haddad, T., Goetz, M. P., Goodnature, B., Cuellar, M. E., Walters, M. A. & 4 others, Correia, C., Kaufmann, S. H., Weinshilboum, R. M. & Wang, L., Jun 15 2020, In : Clinical Cancer Research. 26, 12, p. 2986-2996 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

    Jayaraman, S., Hou, X., Kuffel, M. J., Suman, V. J., Hoskin, T. L., Reinicke, K. E., Monroe, D. G., Kalari, K. R., Tang, X., Zeldenrust, M. A., Cheng, J., Bruinsma, E. S., Buhrow, S. A., McGovern, R. M., Safgren, S. L., Walden, C. A., Carter, J. M., Reid, J. M., Ingle, J. N., Ames, M. M. & 2 others, Hawse, J. R. & Goetz, M. P., May 19 2020, In : Breast Cancer Research. 22, 1, 51.

    Research output: Contribution to journalArticle

    Open Access
  • A transcriptionally definable subgroup of triple-negative breast and ovarian cancer samples shows sensitivity to Hsp90 inhibition

    Shee, K., Wells, J. D., Ung, M., Hampsch, R. A., Traphagen, N. A., Yang, W., Liu, S. C., Zeldenrust, M. A., Wang, L., Kalari, K. R., Yu, J., Boughey, J. C., Demidenko, E., Kettenbach, A. N., Cheng, C., Goetz, M. P. & Miller, T. W., Jan 1 2020, In : Clinical Cancer Research. 26, 1, p. 159-170 12 p.

    Research output: Contribution to journalArticle

  • Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type

    Moyer, A. M., Dukek, B., Duellman, P., Schneider, B., Wakefield, L., Skierka, J. M., Avula, R., Bhagwate, A. V., Kalari, K. R., Kreuter, J. D., Goetz, M. P., Boughey, J. C., Black, J. L. & Gandhi, M. J., 2020, (Accepted/In press) In : Human Immunology.

    Research output: Contribution to journalArticle